A citation-based method for searching scientific literature

N Avril, C A Rosé, M Schelling, J Dose, W Kuhn, S Bense, W Weber, S Ziegler, H Graeff, M Schwaiger. J Clin Oncol 2000
Times Cited: 353







List of co-cited articles
700 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters.
Andreas Buck, Holger Schirrmeister, Thorsten Kühn, Changxian Shen, Thomas Kalker, Jörg Kotzerke, Anja Dankerl, Gerhard Glatting, Sven Reske, Torsten Mattfeldt. Eur J Nucl Med Mol Imaging 2002
214
26

Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography.
Reinhard Bos, Jacobus J M van Der Hoeven, Elsken van Der Wall, Petra van Der Groep, Paul J van Diest, Emile F I Comans, Urvi Joshi, Gregg L Semenza, Otto S Hoekstra, Adriaan A Lammertsma,[...]. J Clin Oncol 2002
412
25

Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.
N Avril, M Menzel, J Dose, M Schelling, W Weber, F Jänicke, W Nathrath, M Schwaiger. J Nucl Med 2001
302
21

Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer.
David Groheux, Sylvie Giacchetti, Jean-Luc Moretti, Raphael Porcher, Marc Espié, Jacqueline Lehmann-Che, Anne de Roquancourt, Anne-Sophie Hamy, Caroline Cuvier, Laetitia Vercellino,[...]. Eur J Nucl Med Mol Imaging 2011
246
21

Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer.
Rakesh Kumar, Anil Chauhan, Hongming Zhuang, Prem Chandra, Mitchell Schnall, Abass Alavi. Breast Cancer Res Treat 2006
131
20

Performance of FDG PET/CT in the clinical management of breast cancer.
David Groheux, Marc Espié, Sylvie Giacchetti, Elif Hindié. Radiology 2013
145
18

Breast cancer detection using high-resolution breast PET compared to whole-body PET or PET/CT.
Judith E Kalinyak, Wendie A Berg, Kathy Schilling, Kathleen S Madsen, Deepa Narayanan, Marie Tartar. Eur J Nucl Med Mol Imaging 2014
54
29

Appearance of untreated bone metastases from breast cancer on FDG PET/CT: importance of histologic subtype.
Brittany Z Dashevsky, Debra A Goldman, Molly Parsons, Mithat Gönen, Adriana D Corben, Maxine S Jochelson, Clifford A Hudis, Monica Morrow, Gary A Ulaner. Eur J Nucl Med Mol Imaging 2015
43
37

Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma.
Molly P Hogan, Debra A Goldman, Brittany Dashevsky, Christopher C Riedl, Mithat Gönen, Joseph R Osborne, Maxine Jochelson, Clifford Hudis, Monica Morrow, Gary A Ulaner. J Nucl Med 2015
38
42

Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancer.
A Gil-Rendo, F Martínez-Regueira, G Zornoza, M J García-Velloso, C Beorlegui, N Rodriguez-Spiteri. Br J Surg 2009
117
14

Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast.
Wendie A Berg, Kathleen S Madsen, Kathy Schilling, Marie Tartar, Etta D Pisano, Linda Hovanessian Larsen, Deepa Narayanan, Al Ozonoff, Joel P Miller, Judith E Kalinyak. Radiology 2011
100
14

Imaging sensitivity of dedicated positron emission mammography in relation to tumor size.
Jae Seon Eo, In Kook Chun, Jin Chul Paeng, Keon Wook Kang, Sang Mi Lee, Wonshik Han, Dong-Young Noh, June-Key Chung, Dong Soo Lee. Breast 2012
44
27

Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures.
David Fuster, Joan Duch, Pilar Paredes, Martín Velasco, Montserrat Muñoz, Gorane Santamaría, Montserrat Fontanillas, Francesca Pons. J Clin Oncol 2008
188
12


High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer.
Wendie A Berg, Irving N Weinberg, Deepa Narayanan, Mary E Lobrano, Eric Ross, Laura Amodei, Lorraine Tafra, Lee P Adler, Joseph Uddo, William Stein,[...]. Breast J 2006
140
11

Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer.
Wendie A Berg, Lorena Gutierrez, Moriel S NessAiver, W Bradford Carter, Mythreyi Bhargavan, Rebecca S Lewis, Olga B Ioffe. Radiology 2004
869
11

Simultaneous whole-body ¹⁸F-FDG PET-MRI in primary staging of breast cancer: a pilot study.
Sangeeta Taneja, Amarnath Jena, Reema Goel, Ramesh Sarin, Sumaid Kaul. Eur J Radiol 2014
48
22

Prognostic impact of (18)FDG-PET-CT findings in clinical stage III and IIB breast cancer.
David Groheux, Elif Hindié, Marc Delord, Sylvie Giacchetti, Anne-sophie Hamy, Cédric de Bazelaire, Anne de Roquancourt, Laetitia Vercellino, Marie-Elisabeth Toubert, Pascal Merlet,[...]. J Natl Cancer Inst 2012
89
12

Comparison of Whole-Body (18)F FDG PET/MR Imaging and Whole-Body (18)F FDG PET/CT in Terms of Lesion Detection and Radiation Dose in Patients with Breast Cancer.
Amy N Melsaether, Roy A Raad, Akshat C Pujara, Fabio D Ponzo, Kristine M Pysarenko, Komal Jhaveri, James S Babb, Eric E Sigmund, Sungheon G Kim, Linda A Moy. Radiology 2016
60
18

Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer.
Shigeto Ueda, Hitoshi Tsuda, Hideki Asakawa, Takashi Shigekawa, Kazuhiko Fukatsu, Nobuo Kondo, Mikio Yamamoto, Yukihiro Hama, Katsumi Tamura, Jiro Ishida,[...]. Jpn J Clin Oncol 2008
154
10

False-positive lesions mimicking breast cancer on FDG PET and PET/CT.
Margaret Adejolu, Lei Huo, Eric Rohren, Lumarie Santiago, Wei T Yang. AJR Am J Roentgenol 2012
75
13

Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer.
Takako Nakai, Chio Okuyama, Takao Kubota, Kei Yamada, Yo Ushijima, Keiko Taniike, Takako Suzuki, Tsunehiko Nishimura. Eur J Nucl Med Mol Imaging 2005
149
9

Value of PET-FDG in primary breast cancer based on histopathological and immunohistochemical prognostic factors.
Pierre Heudel, Sebastien Cimarelli, Anthony Montella, Catherine Bouteille, Thomas Mognetti. Int J Clin Oncol 2010
57
15

Prospective study of 2-[¹⁸F]fluorodeoxyglucose positron emission tomography in the assessment of regional nodal spread of disease in patients with breast cancer: an Ontario clinical oncology group study.
Kathleen I Pritchard, Jim A Julian, Claire M B Holloway, David McCready, Karen Yvonne Gulenchyn, Ralph George, Nicole Hodgson, Peter Lovrics, Francisco Perera, Leela Elavathil,[...]. J Clin Oncol 2012
55
16

Improved differentiation of benign and malignant breast tumors with multiparametric 18fluorodeoxyglucose positron emission tomography magnetic resonance imaging: a feasibility study.
Katja Pinker, Wolfgang Bogner, Pascal Baltzer, Georgios Karanikas, Heinrich Magometschnigg, Peter Brader, Stephan Gruber, Hubert Bickel, Peter Dubsky, Zsuzsanna Bago-Horvath,[...]. Clin Cancer Res 2014
55
16

Dual time point 18F-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes.
Ayse Mavi, Muammer Urhan, Jian Q Yu, Hongming Zhuang, Mohamed Houseni, Tevfik F Cermik, Dhurairaj Thiruvenkatasamy, Brian Czerniecki, Mitchell Schnall, Abass Alavi. J Nucl Med 2006
122
9

Effect of (18)F-FDG PET/CT imaging in patients with clinical Stage II and III breast cancer.
David Groheux, Jean-Luc Moretti, Georges Baillet, Marc Espie, Sylvie Giacchetti, Elif Hindie, Christophe Hennequin, Jacques-Robert Vilcoq, Caroline Cuvier, Marie-Elisabeth Toubert,[...]. Int J Radiat Oncol Biol Phys 2008
88
10

18F-FDG PET of locally invasive breast cancer and association of estrogen receptor status with standardized uptake value: microarray and immunohistochemical analysis.
Joseph R Osborne, Elisa Port, Mithat Gonen, Ashley Doane, Henry Yeung, William Gerald, Josh B Cook, Steven Larson. J Nucl Med 2010
75
12

Evaluation of ¹⁸F-FDG PET/MRI, ¹⁸F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer.
Lino M Sawicki, Johannes Grueneisen, Benedikt M Schaarschmidt, Christian Buchbender, James Nagarajah, Lale Umutlu, Gerald Antoch, Sonja Kinner. Eur J Radiol 2016
54
16

Biological characterisation of breast cancer by means of PET.
Andreas K Buck, Holger Schirrmeister, Torsten Mattfeldt, Sven N Reske. Eur J Nucl Med Mol Imaging 2004
66
12


Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imaging.
Kathy Schilling, Deepa Narayanan, Judith E Kalinyak, Juliette The, Maria Victoria Velasquez, Simone Kahn, Matthew Saady, Ravinder Mahal, Larraine Chrystal. Eur J Nucl Med Mol Imaging 2011
62
12

FDG PET/CT for the detection and evaluation of breast diseases: usefulness and limitations.
Hyo Soon Lim, Woong Yoon, Tae Woong Chung, Jae Kyu Kim, Jin Gyoon Park, Heoung Keun Kang, Hee Seung Bom, Jung Han Yoon. Radiographics 2007
72
11

The yield of 18F-FDG PET/CT in patients with clinical stage IIA, IIB, or IIIA breast cancer: a prospective study.
David Groheux, Sylvie Giacchetti, Marc Espié, Laetitia Vercellino, Anne-Sophie Hamy, Marc Delord, Nathalie Berenger, Marie-Elisabeth Toubert, Jean-Louis Misset, Elif Hindié. J Nucl Med 2011
63
12

Bone metastases in patients with metastatic breast cancer: morphologic and metabolic monitoring of response to systemic therapy with integrated PET/CT.
Ukihide Tateishi, Cristina Gamez, Shaheenah Dawood, Henry W D Yeung, Massimo Cristofanilli, Homer A Macapinlac. Radiology 2008
128
8

Integrated positron emission tomography/computed tomography may render bone scintigraphy unnecessary to investigate suspected metastatic breast cancer.
Patrick G Morris, Colleen Lynch, John N Feeney, Sujata Patil, Jane Howard, Steven M Larson, Maura Dickler, Clifford A Hudis, Maxine Jochelson, Heather L McArthur. J Clin Oncol 2010
79
10

Detection of extra-axillary lymph node involvement with FDG PET/CT in patients with stage II-III breast cancer.
Tjeerd S Aukema, Marieke E Straver, Marie-Jeanne T F D Vrancken Peeters, Nicola S Russell, Kenneth G A Gilhuijs, Wouter V Vogel, Emiel J T Rutgers, Renato A Valdés Olmos. Eur J Cancer 2010
67
11

Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
Leonardo Pace, Emanuele Nicolai, Angelo Luongo, Marco Aiello, Onofrio A Catalano, Andrea Soricelli, Marco Salvatore. Eur J Radiol 2014
95
8

Retrospective analysis of 18F-FDG PET/CT for staging asymptomatic breast cancer patients younger than 40 years.
Christopher C Riedl, Elina Slobod, Maxine Jochelson, Monica Morrow, Debra A Goldman, Mithat Gonen, Wolfgang A Weber, Gary A Ulaner. J Nucl Med 2014
57
14

Breast cancer staging in a single session: whole-body PET/CT mammography.
Till A Heusner, Sherko Kuemmel, Lale Umutlu, Angela Koeninger, Lutz S Freudenberg, Elke A M Hauth, Klaus R Kimmig, Michael Forsting, Andreas Bockisch, Gerald Antoch. J Nucl Med 2008
74
10

Comparison of CE-FDG-PET/CT with CE-FDG-PET/MR in the evaluation of osseous metastases in breast cancer patients.
O A Catalano, E Nicolai, B R Rosen, A Luongo, M Catalano, C Iannace, A Guimaraes, M G Vangel, U Mahmood, A Soricelli,[...]. Br J Cancer 2015
64
12

Clinical utility of 18F-FDG-PET/MR for preoperative breast cancer staging.
Diomidis Botsikas, Anastasia Kalovidouri, Minerva Becker, Michele Copercini, Dahila Amal Djema, Alexandre Bodmer, Sindy Monnier, Christoph D Becker, Xavier Montet, Benedicte M A Delattre,[...]. Eur Radiol 2016
27
29

Evolving role of positron emission tomography in breast cancer imaging.
William B Eubank, David A Mankoff. Semin Nucl Med 2005
104
7

FDG PET, PET/CT, and breast cancer imaging.
Eric L Rosen, William B Eubank, David A Mankoff. Radiographics 2007
140
7



Additional value of PET-CT in staging of clinical stage IIB and III breast cancer.
Isabelle Segaert, Felix Mottaghy, Sarah Ceyssens, Walter De Wever, Sigrid Stroobants, Chantal Van Ongeval, Eric Van Limbergen, Hans Wildiers, Robert Paridaens, Ignace Vergote,[...]. Breast J 2010
61
11

A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases.
U Veronesi, C De Cicco, V E Galimberti, J R Fernandez, N Rotmensz, G Viale, G Spano, A Luini, M Intra, P Veronesi,[...]. Ann Oncol 2007
113
7

Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT.
Gerwin P Schmidt, Andrea Baur-Melnyk, Alexander Haug, Volker Heinemann, Ingo Bauerfeind, Maximilian F Reiser, Stefan O Schoenberg. Eur J Radiol 2008
92
7



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.